Wednesday, December 24, 2025
ADVT 
Health

How genes affect Ebola patients

Darpan News Desk IANS, 31 Oct, 2014 08:14 AM
    New York- The Ebola virus affects different people differently, say researchers, adding that genetic factors could be behind this mild-to-deadly range of reactions to the virus.
     
    While some people completely resist the disease, others suffer moderate to severe illness and recover, while those who are most susceptible succumb to bleeding, organ failure and shock.
     
    These differences are not related to any specific changes in the Ebola virus itself; instead, the body's attempts to fight infection seems to determine disease severity.
     
    "Our data suggest that genetic factors play a significant role in disease outcome," said Michael Katze from University of Washington.
     
    For the study, the researchers examined the role of an individual's genetic makeup in the course of Ebola disease through a mouse model.
     
    The researchers had obtained genetically diverse group of inbred laboratory mice to study locations on mouse genomes associated with influenza severity.
     
    The scientists examined mice that they infected with a mouse form of the same species of Ebola virus causing the 2014 West Africa outbreak.
     
    The scientists found that disease outcomes and variations in mortality rates were co-related to specific genetic lines of mice.
     
    "The frequency of different manifestations of the disease across the lines of these mice screened so far are similar in variety and proportion to the spectrum of clinical disease observed in the 2014 West African outbreak," co-lead researcher Angela Rasmussen from University of Washington pointed out.
     
    Survivors experienced more activity in genes that order blood vessel repair and the production of infection-fighting white blood cells.
     
    The scientists noted that certain specialised types of cells in the liver could also have limited virus reproduction and put a dampener on systemic inflammation and blood clotting problems in resistant mice.
     
    "We hope that medical researchers will be able to rapidly apply these findings to candidate therapeutics and vaccines," Katze stressed.
     
    The study appeared in the journal Science.

    MORE Health ARTICLES

    Pro-euthanasia group's poll shows overwhelming support for assisted dying in Canada

    Pro-euthanasia group's poll shows overwhelming support for assisted dying in Canada
    TORONTO - An overwhelming majority of Canadians surveyed in an online poll support assisted dying for those suffering from a terminal illness that results in "unbearable suffering," a pro-euthanasia group said Wednesday, ahead of a Supreme Court of Canada hearing on the controversial issue.

    Pro-euthanasia group's poll shows overwhelming support for assisted dying in Canada

    Sugary drinks could lead to poor memory in kids

    Sugary drinks could lead to poor memory in kids
    Consuming a diet high in added sugar could not only lead to weight gain among kids, but could also negatively affect their memory, suggested a study....

    Sugary drinks could lead to poor memory in kids

    Why testosterone may increase prostate cancer risk

    Why testosterone may increase prostate cancer risk
    While an adequate testosterone level is essential for men to maintain energy, sex drive and reproductive capacity, unnecessary testosterone...

    Why testosterone may increase prostate cancer risk

    1 In 10 Canadian ER Patients Face 28 Hours of Wait for Beds, Especially Seniors

    1 In 10 Canadian ER Patients Face 28 Hours of Wait for Beds, Especially Seniors
    TORONTO - A new reports says one in 10 emergency department patients who need hospital admission have to wait more than 28 hours on average before being transferred to a bed.

    1 In 10 Canadian ER Patients Face 28 Hours of Wait for Beds, Especially Seniors

    Cancer grows and spreads at night

    Cancer grows and spreads at night
    Cancer grows and spreads in the body at night, shows a study, suggesting that it could be more efficient to administer certain anti-cancer drugs at night....

    Cancer grows and spreads at night

    New device can control heart failure

    New device can control heart failure
    A new, implantable device to control heart failure is showing promising results in the first trial to determine safety and effectiveness in patients, a significant study shows....

    New device can control heart failure